Press Releases August 10, 2026 09:43 AM

Verisk Responds to Delaware Chancery Court Ruling Regarding AccuLynx

Verisk responds to Delaware court ruling on AccuLynx and considers appeal options

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
VRSK

Verisk, a Nasdaq-listed data analytics company serving the insurance industry, issued a statement disagreeing with a recent ruling by the Delaware Chancery Court regarding AccuLynx. The company is evaluating possible appeal and other responses to the court's expedited decision.

Verisk Responds to Delaware Chancery Court Ruling Regarding AccuLynx
VRSK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Verisk strongly disagrees with the Delaware Chancery Court's ruling concerning AccuLynx.
  • The company is exploring legal options including an appeal in response to the decision.
  • Verisk continues to focus on providing advanced data analytics and technology solutions to the global insurance sector.

JERSEY CITY, N.J., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading data analytics and technology provider to the global insurance industry, today issued the following statement in response to the Delaware Chancery Court ruling regarding AccuLynx:

“We appreciate the expedited response from the court but strongly disagree with the decision. It is possible to appeal, among other next steps, and we are evaluating our options at this time.”

About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, catastrophic events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work. For more, visit Verisk.com and the Verisk Newsroom.


Risks

  • Uncertainty around the legal outcome related to AccuLynx could impact Verisk's operations or financial performance.
  • Potential distraction and costs associated with ongoing legal proceedings.
  • The ruling and its implications may affect investor sentiment in the insurance technology and data analytics sector.

More from Press Releases

LPL Financial Opens Focus 2026, Bringing Together Thousands of Advisors to Explore the Future of Wealth Management Aug 10, 2026 Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston Aug 10, 2026 Trupanion Enhances Free Veterinary Education Course to Help Hospital Teams Navigate Cost-of-Care Conversations Aug 10, 2026 ARIA Cybersecurity Announces OpenAI’s attack on Hugging Face could have been prevented by AZT PROTECT Aug 10, 2026 SPP Credit Advisors and Circle8 Group Eliminate $35 Million Convertible Seller's Note in Global Settlement Agreement Aug 10, 2026